Cancer researchers now can visualize more of a tumor than ever before using PerkinElmer’s Phenoptics Quantitative Pathology Research Solutions. In a melanoma case study, Dr. Tumeh uses this instrumentation to develop biomarkers in his cancer immunology research.
Using the Attivo and SciBite TERMite platforms, researchers can now unlock the value of unstructured data found in electronic medical records, to reveal medical discoveries that would otherwise be lost in too much data.
A new generation of high-content imaging systems such as the PerkinElmer Operetta CLS High Content Imaging System and Harmony High Content Imaging and Analysis Software are helping scientists to blaze new trails in cancer drug therapy.
Scientists at UCLA's David Geffen School of Medicine are working with bioluminescent, fluorescent, and positron emission tomography (PET) technologies to reduce infections in post-surgical orthopedic patients as well as fight against metabolic cancer.
PerkinElmer and University of Colorado scientists review the current state of high-content (3D) imaging technologies that are advancing rapidly in the biological and biochemical sectors.
Researchers offer evidence of the importance of epithelial-to-mesenchymal transition (EMT) in the progression of chronic kidney disease.
Using TIBCO Spotfire® visualization tools, PerkinElmer demonstrates this analytical versatile software in the study of infectious diseases.
Using a suite of PerkinElmer's analytical imaging instruments, Dementias Platform United Kingdom (DPUK) is taking a whole-body approach to early detection, better treatment, and prevention of neurodegenerative conditions including Parkinson’s Disease, Motor Neurone Diseases, Multiple Sclerosis, Huntington’s Disease, Creutzfeldt–Jakob Disease, and Alzheimer’s Disease.
Scientists morph stem cells into mini-brains to prove that the Zika virus causes massive brain cell death in fetuses.
Using high content cellular imaging to engineer new drug therapies to combat human diseases.